DCFGX
Price
$27.02
Change
-$1.77 (-6.15%)
Updated
Apr 4 closing price
Net Assets
165.82M
RGACX
Price
$60.87
Change
-$3.73 (-5.77%)
Updated
Apr 4 closing price
Net Assets
248.76B
Ad is loading...

DCFGX vs RGACX

Header iconDCFGX vs RGACX Comparison
Open Charts DCFGX vs RGACXBanner chart's image
Dunham Focused Large Cap Growth C
Price$27.02
Change-$1.77 (-6.15%)
VolumeN/A
Net Assets165.82M
American Funds Growth Fund of Amer R3
Price$60.87
Change-$3.73 (-5.77%)
VolumeN/A
Net Assets248.76B
DCFGX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DCFGX vs. RGACX commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCFGX is a Hold and RGACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 249B vs. DCFGX (166M). RGACX pays higher dividends than DCFGX: RGACX (0.09) vs DCFGX (0.00). DCFGX was incepted earlier than RGACX: DCFGX (13 years) vs RGACX (23 years). DCFGX (2.23) is less costly to investors than RGACX (0.94). RGACX is a more actively managed with annual turnover of: 25.00 vs. DCFGX (11.00). RGACX has a lower initial minimum investment than DCFGX: RGACX (250) vs DCFGX (5000). RGACX annual gain was more profitable for investors over the last year : -10.20 vs. DCFGX (-23.02). RGACX return over 5 years is better than : 49.81 vs. DCFGX (39.28).
DCFGXRGACXDCFGX / RGACX
Total Expense Ratio2.230.94237%
Annual Report Gross Expense Ratio2.230.94237%
Fund Existence13 years23 years-
Gain YTD-21.040-15.447136%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets166M249B0%
Annual Yield % from dividends0.000.09-
Returns for 1 year-23.02-10.20226%
Returns for 3 years-8.62-5.46158%
Returns for 5 years39.2849.8179%
Returns for 10 years73.2139.96183%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYGR3.09-0.02
-0.64%
Voyager Therapeutics
PHVS14.28-0.34
-2.33%
Pharvaris NV
QTWO70.31-5.28
-6.99%
Q2 Holdings
GOVX1.02-0.08
-7.27%
GeoVax Labs
OKTA91.93-8.34
-8.32%
Okta